Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
5(56%)
Results Posted
67%(2 trials)

Phase Distribution

Ph phase_2
2
22%
Ph not_applicable
4
44%
Ph phase_3
1
11%
Ph phase_1
2
22%

Phase Distribution

2

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
2(22.2%)
Phase 2Efficacy & side effects
2(22.2%)
Phase 3Large-scale testing
1(11.1%)
N/ANon-phased studies
4(44.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

5

trials recruiting

Total Trials

9

all time

Status Distribution
Active(5)
Completed(3)
Terminated(1)

Detailed Status

Active, not recruiting4
Completed3
Withdrawn1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
5
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (22.2%)
Phase 22 (22.2%)
Phase 31 (11.1%)
N/A4 (44.4%)

Trials by Status

active_not_recruiting444%
withdrawn111%
completed333%
recruiting111%

Recent Activity

5 active trials
Showing 5 of 9
active_not_recruitingphase_3

Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma

NCT02306161
recruitingphase_1

Evaluation of Abemaciclib and Radiation Therapy Before Surgery for the Treatment of High-Risk Adipocytic Retroperitoneal Sarcoma

NCT06025747
active_not_recruitingnot_applicable

Radiation Therapy Boost Before Surgery for the Treatment of Non-metastatic Breast Cancer

NCT04871516
active_not_recruitingphase_1

Short-Course Chemoradiotherapy Followed by Chemotherapy for the Treatment of Resectable Gastric Adenocarcinoma

NCT04523818
active_not_recruitingnot_applicable

MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ

NCT02352883
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT02306161Phase 3

Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma

Active Not Recruiting
NCT06025747Phase 1

Evaluation of Abemaciclib and Radiation Therapy Before Surgery for the Treatment of High-Risk Adipocytic Retroperitoneal Sarcoma

Recruiting
NCT04871516Not Applicable

Radiation Therapy Boost Before Surgery for the Treatment of Non-metastatic Breast Cancer

Active Not Recruiting
NCT04523818Phase 1

Short-Course Chemoradiotherapy Followed by Chemotherapy for the Treatment of Resectable Gastric Adenocarcinoma

Active Not Recruiting
NCT02352883Not Applicable

MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ

Active Not Recruiting
NCT01233479Not Applicable

Biomarkers in Blood Samples From Young Patients With Newly Diagnosed Brain Tumors Undergoing Standard Radiation Therapy and Chemotherapy

Withdrawn
NCT00686166Phase 2

S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer

Completed
NCT00647218Not Applicable

Paclitaxel and Radiation Therapy in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer

Completed
NCT00645866Phase 2

Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast Cancer

Completed

All 9 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
9